Systemic pathology is more evident in severe SMA-type 1 patients, but it is gaining importance with the advent of new disease-phenotypes due to SMN-rescue therapies, which are modifying SMA natural history (Yeo and Darras, 2020). The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.